🩸Current treatments for #haemophilia A do not provide a definitive cure for the disease.

#EUfunded researchers have developed a novel innovative cell therapy for its treatment.

Read more about the study👉https://europa.eu/!CM4xrc

🐦🔗: https://n.respublicae.eu/CORDIS_EU/status/1647870081907531778

RT @EMA_News@twitter.com

The #CHMP recommended for authorisation the 1⃣st gene therapy to treat #haemophilia B in adults ⬇️

https://www.ema.europa.eu/en/news/first-gene-therapy-treat-haemophilia-b

🐦🔗: https://twitter.com/EMA_News/status/1603711318233649152

The #CHMP recommended for authorisation the 1⃣st gene therapy to treat #haemophilia B in adults ⬇️

https://www.ema.europa.eu/en/news/first-gene-therapy-treat-haemophilia-b

🐦🔗: https://n.respublicae.eu/EMA_News/status/1603711318233649152

This is amazing! I feel super privileged to have been a tiny small part of this trial. I’m excited to see what happens next 🙂

RT @ProfMakris@twitter.com

Important day in the history of #haemophilia treatment. Today the first ever gene therapy for #hemophilia B has been approved by the FDA in the US. So now we have approved gene therapy for hemophilia A in Europe and hemophilia B in the US. https://tinyurl.com/2s3bujyb

🐦🔗: https://twitter.com/ProfMakris/status/1595157792016732161

RT @meganhfn@twitter.com

DO YOU KNOW?
With the prevalence of Haemophillia, Nigeria is expected to have about 21,500 persons living with haemophilia but only 698 have so far been diagnosed and captured in the registry. This represents 3.24% identification rate #bleedingdisorders #haemophilia #hfn

🐦🔗: https://twitter.com/meganhfn/status/1592475023423729664